[Thrombolytic therapy using r-TPA in Budd-Chiari syndrome in the course of myeloproliferative diseases].

Casciaro, S; Ghio, R; Balleari, E; Boccaccio, G

[Thrombolytic therapy using r-TPA in Budd-Chiari syndrome in the course of myeloproliferative diseases]. / Trattamento trombolitico con r-TPA nella sindrome di Budd-Chiari in corso di malattie mieloproliferative.

Casciaro, S; Ghio, R; Balleari, E; Boccaccio, G.

Affiliation

Casciaro S; Azienda Ospedaliera Ospedale S. Martino, Genova.

Minerva Cardioangiol ; 46(7-8): 241-53, 1998.

Article in It | MEDLINE | ID: mdl-9973787

Subject(s)

Budd-Chiari Syndrome/etiology; Fibrinolytic Agents/therapeutic use; Myeloproliferative Disorders/complications; Tissue Plasminogen Activator/therapeutic use; Budd-Chiari Syndrome/drug therapy; Humans; Male; Middle Aged; Thrombolytic Therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tissue Plasminogen Activator / Fibrinolytic Agents / Budd-Chiari Syndrome / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Humans / Male / Middle aged Language: It Journal: Minerva Cardioangiol Year: 1998 Document type: Article Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links